Streetbeat News

Revenues

SIG

Signet Jewelers forecasts Q1 revenue to be between $1.47B and $1.53B, which is at the lower end of the $1.53B estimate. The company also expects same store sales to decrease by 11% to 7%.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 10:54 am

JILL

J.Jill projects its fiscal year 2024 net sales to remain stable or experience a slight increase in the low-single digits.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 10:49 am

BNTX

BioNTech forecasts FY2024 sales to be between €2.5B and €3.1B, with R&D expenses projected at €2.4B-€2.6B, SG&A expenses at €700M-€800M, and capital expenditure estimated to be €400M-€500M.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 10:20 am

BNTX

BioNTech announced the delivery of over 400 million Covid-19 vaccine doses globally in 2023, including a vaccine adapted to the XBB.1.5 variant. This achievement underscores the company's ongoing contribution to combating the pandemic.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 10:17 am

EVTV

Envirotech Vehicles (EVTV) has entered into a sales and purchase agreement with PlugD Commercial Electric Leasing and Rentals, valued at $16.2 million. EVTV will deliver 200 electric high roof vans and trucks to PlugD over the next 13 months.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 10:04 am

BA

SPR

At the BofA Securities Global Industrials Conference, Boeing's CFO announced a decision to limit 737 production below 38 units per month, impacting the company's revenue, earnings, and cash flow for the year and quarter.

Portfolio Pulse from Charles Gross

March 20, 2024 | 9:56 am

SY

So-Young International Inc. projects its Q1 FY2024 revenues to be between RMB290 million ($40.8 million) and RMB310 million ($43.7 million), indicating a potential year-over-year decrease of up to 6.5%.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 9:50 am

HUIZ

Huize Holding (NASDAQ:HUIZ) reported a decrease in Q4 sales to $33.24 million, down 11.28% from $37.47 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 9:07 am

NVO

Ross Gerber, a notable Tesla investor, highlighted on X (formerly Twitter) the potential cost-saving benefits of using Ozempic, a weight-loss drug by Novo Nordisk A/S (NYSE:NVO). He suggested that the drug could reduce monthly food expenses significantly, citing a user's experience of saving nearly $1,000 a month. The discussion also touched on the broader implications for the food and beverage industry and the public's skepticism towards new weight loss drugs despite high-profile endorsements.

Portfolio Pulse from Benzinga Neuro

March 20, 2024 | 8:20 am

EWU

The U.K. Consumer Prices Index Including Owner Occupiers' Housing Costs (CPIH) year-over-year has decreased to 3.8% from the previous 4.2%.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 7:03 am